Searle & Co’s AstraZeneca AZN Stock Holding History

Searle & Co’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-17,675	Closed	-$3.42M	–	196
2026 Q1	$3.42M	Hold	17,675	–	–	0.86%	32
2025 Q4	$3.25M	Hold	17,675	–	–	0.84%	36
2025 Q3	$2.71M	Hold	17,675	–	–	0.72%	39
2025 Q2	$2.47M	Hold	17,675	–	–	0.7%	41
2025 Q1	$2.6M	Hold	17,675	–	–	0.74%	38
2024 Q4	$2.32M	Hold	17,675	–	–	0.67%	41
2024 Q3	$2.75M	Hold	17,675	–	–	0.69%	36
2024 Q2	$2.76M	Hold	17,675	–	–	0.65%	37
2024 Q1	$2.39M	Hold	17,675	–	–	0.61%	40
2023 Q4	$2.38M	Hold	17,675	–	–	0.65%	41
2023 Q3	$2.39M	Hold	17,675	–	–	0.81%	34
2023 Q2	$2.53M	Hold	17,675	–	–	0.79%	37
2023 Q1	$2.59M	Hold	17,675	–	–	0.85%	36
2022 Q4	$2.4M	Hold	17,675	–	–	0.82%	37
2022 Q3	$1.94M	Hold	17,675	–	–	0.75%	43
2022 Q2	$2.34M	Sell	17,675 -125	-0.7%	-$16.4K	0.92%	34
2022 Q1	$2.36M	Hold	17,800	–	–	0.87%	40
2021 Q4	$2.07M	Hold	17,800	–	–	0.75%	45
2021 Q3	$2.14M	Hold	17,800	–	–	0.88%	43
2021 Q2	$2.13M	Hold	17,800	–	–	0.87%	43
2021 Q1	$1.77M	Hold	17,800	–	–	0.79%	46
2020 Q4	$1.78M	Buy	17,800 +100	+0.6%	+$10.6K	0.86%	45
2020 Q3	$1.94M	Hold	17,700	–	–	1.06%	36
2020 Q2	$1.87M	Hold	17,700	–	–	1.09%	32
2020 Q1	$1.58M	Hold	17,700	–	–	1.12%	33
2019 Q4	$1.76M	Buy	17,700 +125	+0.7%	+$11.8K	0.97%	36
2019 Q3	$1.57M	Sell	17,575 -125	-0.7%	-$10.8K	0.92%	38
2019 Q2	$1.46M	Hold	17,700	–	–	0.89%	39
2019 Q1	$1.43M	Hold	17,700	–	–	0.89%	39
2018 Q4	$1.34M	Hold	17,700	–	–	0.95%	38
2018 Q3	$1.4M	Sell	17,700 -125	-0.7%	-$9.45K	0.82%	41
2018 Q2	$1.25M	Hold	17,825	–	–	0.79%	42
2018 Q1	$1.25M	Hold	17,825	–	–	0.81%	42
2017 Q4	$1.24M	Sell	17,825 -700	-4%	-$47.2K	0.78%	44
2017 Q3	$1.25M	Hold	18,525	–	–	0.83%	46
2017 Q2	$1.26M	Sell	18,525 -63	-0.3%	-$4.11K	0.87%	43
2017 Q1	$1.16M	Hold	18,588	–	–	0.81%	43
2016 Q4	$1.02M	Sell	18,588 -62	-0.3%	-$3.52K	0.84%	44
2016 Q3	$1.22M	Buy	+18,650	New	+$1.22M	1.06%	33
2016 Q2	–	Sell	-18,650	Closed	-$1.05M	–	31
2016 Q1	$1.05M	Sell	18,650 -1,000	-5%	-$60.1K	0.97%	40
2015 Q4	$1.31M	Buy	19,650 +1,500	+8%	+$98.3K	1.26%	26
2015 Q3	$1.16M	Sell	18,150 -1,500	-8%	-$98.7K	1.19%	28
2015 Q2	$1.25M	Hold	19,650	–	–	1.04%	30
2015 Q1	$1.34M	Hold	19,650	–	–	1.16%	27
2014 Q4	$1.38M	Buy	+19,650	New	+$1.41M	1.17%	20

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Searle & Co's AZN Position: Q2 2026 in Review

Searle & Co sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 17,675 shares — an estimated $3.42M sold.

Searle & Co first reported a position in AZN in Q4 2014 and held it in 45 quarters. The position peaked at $3.42M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Searle & Co reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
Searle & Co sold 17,675 AstraZeneca shares in Q2 2026, an estimated $3.42M.
Searle & Co first reported a position in AstraZeneca in Q4 2014 and held it in 45 quarters.
Searle & Co's AstraZeneca position peaked at $3.42M in Q1 2026.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Searle & Co's 13F filing for Q2 2026, filed 27 Jul 2026.